Please Wait.....
Report
Latin America Respiratory Inhalers Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America Respiratory Inhalers Market Report and Forecast 2024-2032
Latin America Respiratory Inhalers Market Size
The global respiratory inhalers market was valued at USD 33.5 billion in 2023, with Latin America holding a significant market share. The market is driven by the rising incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is expected to grow at a CAGR of 5.4% during the forecast period of 2024-2032, with the values likely to attain USD 53.9 billion by 2032.
Latin America Respiratory Inhalers Market Outlook
- Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition in the Latin American region, particularly in men, smokers and ex-smokers. The rising burden of respiratory diseases is expected to directly impact the market demand.
- One of the major Latin America respiratory inhalers market trends is the growing focus on the development of eco-friendly respiratory inhaler products. In April 2024, Mundipharma and Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform used in a pressurized metered-dose inhaler (pMDI) to reduce the product's carbon footprint.
- The growing adoption of technologically advanced inhaler devices such as digital inhalers that offer additional features such as tracking medication usage and dosage are likely to boost the market share.
Latin America Respiratory Inhalers Market Analysis
Respiratory inhalers are medical devices that are designed to provide quick relief from respiratory symptoms or deliver medication to manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Metered-dose inhalers are the most common type of inhalers that use a propellant to spray out the medication in a short burst. There is an increasing use of technologically advanced inhaler devices such as digital inhalers that offer additional features such as tracking medication usage and dosage. The rising adoption of such innovative inhaler solutions to monitor patient compliance and adherence is expected to propel the Latin America respiratory inhalers market growth.
In Latin America, the increasing burden of respiratory diseases is directly impacting the market dynamics. Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition in the Latin American region, particularly in men and in smokers and ex-smokers, which drives the demand for advanced respiratory inhalers. Further, in April 2023, a study reported that the healthcare costs associated with exacerbation of COPD are very high in Brazil, reaching an amount of nearly USD 14,657 per hospitalization. This indicates the need for effective respiratory care products including inhalers to prevent the worsening of COPD symptoms and ensure consistent and proper dosing of medications, which is likely to augment the Latin America respiratory inhalers market demand.
One of the major market trends is the growing focus on the development of sustainable healthcare solutions including the development of eco-friendly respiratory inhaler products. For instance, in April 2024, global healthcare company Mundipharma and specialist inhalation contract development and manufacturing organization Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform (indicated in the regular treatment of asthma) used in a pressurized metered-dose inhaler (pMDI) with the aim of reducing the product's carbon footprint. Such substantial investment in the advancement of respiratory inhalers with a lower environmental impact is anticipated to elevate the market value in the forecast period.
Latin America Respiratory Inhalers Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Dry Powdered Inhalers
o Multi-Dose Dry Powder Inhalers
o Single Dose Dry Powder Inhalers
- Metered Dose Inhalers
o Pressured Metered Dose Inhalers
o Connected Metered Dose Inhalers
- Nebulizers
o Compressed Air Nebulizers
o Mesh Air Nebulizers
o Ultrasonic Air Nebulizers
Market Breakup by Technology
- Manually Operated Inhaler
- Digitally Operated Inhaler
Market Breakup by Indication
- Asthma
- COPD
- Pulmonary Arterial Hypertension
- Other Respiratory Diseases
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by End Use
- Hospitals and Clinics
- Homecare Settings
- Respiratory Care Centres
- Others
Market Breakup by Country
- Brazil
- Argentina
- Mexico
- Others
Leading Players in the Latin America Respiratory Inhalers Market
The key features of the market report include partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- PARI Respiratory Equipment, Inc.
- OPKO Health, Inc
- Teva Pharmaceutical Industries Ltd
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America respiratory inhalers market forecast outlook for 2024-2032?
The Latin America respiratory inhalers market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 53.9 billion by 2032.
- What are the major factors aiding the Latin America respiratory inhalers market demand?
The rising incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is fuelling the demand for the market.
- What are the major Latin America respiratory inhalers market trends?
One of the significant trends in the market is the rising emphasis on the development of eco-friendly respiratory inhaler products. For instance, in April 2024, Mundipharma and Vectura announced plans to incorporate an environmentally friendly propellant into the reformulation of flutiform used in a pressurized metered-dose inhaler (pMDI) to reduce the product's carbon footprint.
- What is the market segmentation based on the product type?
Based on the product type, the market is segmented into dry powdered inhalers (multi-dose dry powder inhalers, single dose dry powder inhalers), metered dose inhalers (pressured metered dose inhalers, connected metered dose inhalers), and nebulizers (compressed air nebulizers, mesh air nebulizers, ultrasonic air nebulizers), among others.
- What is the market breakup by technology?
By technology, the market is divided into manually operated inhalers and digitally operated inhalers.
- What is the market breakup by indication?
By indication, the market includes asthma, COPD, and pulmonary arterial hypertension, among other respiratory diseases.
- What is the market breakup by end use?
By end use, the market is segmented into hospitals and clinics, homecare settings, respiratory care centers and others.
- What are the distribution channels of the market?
Major distribution channels of the market include hospital pharmacies, retail pharmacies and online pharmacies.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America respiratory inhalers market?
The key players in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Cipla Ltd, GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc., OPKO Health, Inc., and Teva Pharmaceutical Industries Ltd.
Meta description
The Latin America respiratory inhalers market is poised for growth, driven by the expansion of the global market, which was valued at USD 33.5 billion in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Respiratory Inhalers Market Overview
3.1 Latin America Respiratory Inhalers Market Historical Value (2017-2023)
3.2 Latin America Respiratory Inhalers Market Forecast Value (2024-2032)
4 Latin America Respiratory Inhalers Market Landscape*
4.1 Latin America Respiratory Inhalers Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Respiratory Inhalers Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Material
4.2.3 Analysis by Type
5 Latin America Respiratory Inhalers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Respiratory Inhalers Market Segmentation (2017-2032)
6.1 Latin America Respiratory Inhalers Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Dry Powdered Inhalers
6.1.2.1 Multi-Dose Dry Powder Inhalers
6.1.2.2 Single Dose Dry Powder Inhalers
6.1.3 Metered Dose Inhalers
6.1.3.1 Pressured Metered Dose Inhalers
6.1.3.2 Connected Metered Dose Inhalers
6.1.4 Nebulizers
6.1.4.1 Compressed Air Nebulizers
6.1.4.2 Mesh Air Nebulizers
6.1.4.3 Ultrasonic Air Nebulizers
6.1.5 Others
6.2 Latin America Respiratory Inhalers Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Manually Operated Inhaler
6.2.3 Digitally Operated Inhaler
6.3 Latin America Respiratory Inhalers Market (2017-2032) by Indication
6.3.1 Market Overview
6.3.2 Asthma
6.3.3 COPD
6.3.4 Pulmonary Arterial Hypertension
6.3.5 Other Respiratory Diseases
6.4 Latin America Respiratory Inhalers Market (2017-2032) by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospital Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Online Pharmacies
6.5 Latin America Respiratory Inhalers Market (2017-2032) by End Use
6.5.1 Market Overview
6.5.2 Hospitals & Clinics
6.5.3 Homecare Settings
6.5.4 Respiratory Care Centers
6.5.5 Others
6.6 Latin America Respiratory Inhalers Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.2 Brazil
6.6.3 Argentina
6.6.4 Mexico
6.6.5 Others
7 Brazil Respiratory Inhalers Market (2017-2032)
7.1 Brazil Respiratory Inhalers Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Dry Powdered Inhalers
7.1.2.1 Multi-Dose Dry Powder Inhalers
7.1.2.2 Single Dose Dry Powder Inhalers
7.1.3 Metered Dose Inhalers
7.1.3.1 Pressured Metered Dose Inhalers
7.1.3.2 Connected Metered Dose Inhalers
7.1.4 Nebulizers
7.1.4.1 Compressed Air Nebulizers
7.1.4.2 Mesh Air Nebulizers
7.1.4.3 Ultrasonic Air Nebulizers
7.1.5 Others
7.2 Brazil Respiratory Inhalers Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Manually Operated Inhaler
7.2.3 Digitally Operated Inhaler
7.3 Brazil Respiratory Inhalers Market (2017-2032) by Indication
7.3.1 Market Overview
7.3.2 Asthma
7.3.3 COPD
7.3.4 Pulmonary Arterial Hypertension
7.3.5 Other Respiratory Diseases
7.4 Brazil Respiratory Inhalers Market (2017-2032) by Distribution Channel
7.4.1 Market Overview
7.4.2 Hospital Pharmacies
7.4.3 Retail Pharmacies
7.4.4 Online Pharmacies
7.5 Brazil Inhalers Market (2017-2032) by End Use
7.5.1 Market Overview
7.5.2 Hospitals & Clinics
7.5.3 Homecare Settings
7.5.4 Respiratory Care Centers
7.5.5 Others
8 Argentina Respiratory Inhalers Market (2017-2032)
8.1 Argentina Respiratory Inhalers Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Dry Powdered Inhalers
8.1.2.1 Multi-Dose Dry Powder Inhalers
8.1.2.2 Single Dose Dry Powder Inhalers
8.1.3 Metered Dose Inhalers
8.1.3.1 Pressured Metered Dose Inhalers
8.1.3.2 Connected Metered Dose Inhalers
8.1.4 Nebulizers
8.1.4.1 Compressed Air Nebulizers
8.1.4.2 Mesh Air Nebulizers
8.1.4.3 Ultrasonic Air Nebulizers
8.1.5 Others
8.2 Argentina Respiratory Inhalers Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Manually Operated Inhaler
8.2.3 Digitally Operated Inhaler
8.3 Argentina Respiratory Inhalers Market (2017-2032) by Indication
8.3.1 Market Overview
8.3.2 Asthma
8.3.3 COPD
8.3.4 Pulmonary Arterial Hypertension
8.3.5 Other Respiratory Diseases
8.4 Argentina Respiratory Inhalers Market (2017-2032) by Distribution Channel
8.4.1 Market Overview
8.4.2 Hospital Pharmacies
8.4.3 Retail Pharmacies
8.4.4 Online Pharmacies
8.5 Argentina Respiratory Inhalers Market (2017-2032) by End Use
8.5.1 Market Overview
8.5.2 Hospitals & Clinics
8.5.3 Homecare Settings
8.5.4 Respiratory Care Centers
8.5.5 Others
9 Mexico Respiratory Inhalers Market (2017-2032)
9.1 Mexico Respiratory Inhalers Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Dry Powdered Inhalers
9.1.2.1 Multi-Dose Dry Powder Inhalers
9.1.2.2 Single Dose Dry Powder Inhalers
9.1.3 Metered Dose Inhalers
9.1.3.1 Pressured Metered Dose Inhalers
9.1.3.2 Connected Metered Dose Inhalers
9.1.4 Nebulizers
9.1.4.1 Compressed Air Nebulizers
9.1.4.2 Mesh Air Nebulizers
9.1.4.3 Ultrasonic Air Nebulizers
9.1.5 Others
9.2 Mexico Respiratory Inhalers Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Manually Operated Inhaler
9.2.3 Digitally Operated Inhaler
9.3 Mexico Respiratory Inhalers Market (2017-2032) by Indication
9.3.1 Market Overview
9.3.2 Asthma
9.3.3 COPD
9.3.4 Pulmonary Arterial Hypertension
9.3.5 Other Respiratory Diseases
9.4 Mexico Respiratory Inhalers Market (2017-2032) by Distribution Channel
9.4.1 Market Overview
9.4.2 Hospital Pharmacies
9.4.3 Retail Pharmacies
9.4.4 Online Pharmacies
9.5 Mexico Respiratory Inhalers Market (2017-2032) by End Use
9.5.1 Market Overview
9.5.2 Hospitals & Clinics
9.5.3 Homecare Settings
9.5.4 Respiratory Care Centers
9.5.5 Others
10 Regulatory Framework
11 Partnership and Collaborations Analysis
11.1 Analysis by Partnership Instances
11.2 Analysis by Type of Partnership
11.3 Analysis by Leading Players
11.4 Analysis by Geography
12 Supplier Landscape
12.1 Market Share by Top 5 Companies
12.2 AstraZeneca Plc
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.2.5 Certifications
12.3 Beximco Pharmaceuticals Ltd.
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.3.5 Certifications
12.4 Boehringer Ingelheim International GmbH
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.4.5 Certifications
12.5 Cipla Ltd
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.5.5 Certifications
12.6 GSK Plc
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.6.5 Certifications
12.7 Koninklijke Philips NV
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.7.5 Certifications
12.8 OMRON Corp
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.8.5 Certifications
12.9 PARI Respiratory Equipment, In
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.9.5 Certifications
12.10 OPKO Health, Inc
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
12.10.5 Certifications
12.11 Teva Pharmaceutical Industries Ltd
12.11.1 Financial Analysis
12.11.2 Product Portfolio
12.11.3 Demographic Reach and Achievements
12.11.4 Mergers and Acquisitions
12.11.5 Certifications
13 Latin America Respiratory Inhalers Market - Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
16.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security